Yang Q, Li F, Jia G, Liu R. Aged black garlic extract inhibits the growth of estrogen receptor-positive breast cancer cells by downregulating MCL-1 expression through the ROS-JNK pathway. PLoS ONE. 2023;18:e0286454 pubmed publisher

Yang H, Gao Y, Xu D, Xu K, Liang S, Yang Z, et al. MEK1 drives oncogenic signaling and interacts with PARP1 for genomic and metabolic homeostasis in malignant pleural mesothelioma. Cell Death Discov. 2023;9:55 pubmed publisher

Hanrahan A, SYLVESTER B, Chang M, Elzein A, Gao J, Han W, et al. Leveraging systematic functional analysis to benchmark an in silico framework distinguishes driver from passenger MEK mutants in cancer. Cancer Res. 2020;: pubmed publisher

Chao M, Chang L, Tu H, Chang C, Lai M, Chen Y, et al. Combination treatment strategy for pancreatic cancer involving the novel HDAC inhibitor MPT0E028 with a MEK inhibitor beyond K-Ras status. Clin Epigenetics. 2019;11:85 pubmed publisher

Bielski C, Donoghue M, Gadiya M, Hanrahan A, Won H, Chang M, et al. Widespread Selection for Oncogenic Mutant Allele Imbalance in Cancer. Cancer Cell. 2018;34:852-862.e4 pubmed publisher

Azorsa D, Lee D, Wai D, Bista R, Patel A, Aleem E, et al. Clinical resistance associated with a novel MAP2K1 mutation in a patient with Langerhans cell histiocytosis. Pediatr Blood Cancer. 2018;65:e27237 pubmed publisher

Mita P, Wudzinska A, Sun X, Andrade J, Nayak S, Kahler D, et al. LINE-1 protein localization and functional dynamics during the cell cycle. elife. 2018;7: pubmed publisher

Li W, Reeb A, Lin B, Subramanian P, Fey E, Knoverek C, et al. Heat Shock-induced Phosphorylation of TAR DNA-binding Protein 43 (TDP-43) by MAPK/ERK Kinase Regulates TDP-43 Function. J Biol Chem. 2017;292:5089-5100 pubmed publisher

Gao J, Chang M, Johnsen H, Gao S, SYLVESTER B, Sumer S, et al. 3D clusters of somatic mutations in cancer reveal numerous rare mutations as functional targets. Genome Med. 2017;9:4 pubmed publisher

Dhawan N, Scopton A, Dar A. Small molecule stabilization of the KSR inactive state antagonizes oncogenic Ras signalling. Nature. 2016;537:112-116 pubmed publisher

Arcila M, Drilon A, SYLVESTER B, Lovly C, Borsu L, Reva B, et al. MAP2K1 (MEK1) Mutations Define a Distinct Subset of Lung Adenocarcinoma Associated with Smoking. Clin Cancer Res. 2015;21:1935-43 pubmed publisher

Chakraborty R, Hampton O, Shen X, Simko S, Shih A, Abhyankar H, et al. Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis. Blood. 2014;124:3007-15 pubmed publisher

Brannon A, Vakiani E, SYLVESTER B, Scott S, McDermott G, Shah R, et al. Comparative sequencing analysis reveals high genomic concordance between matched primary and metastatic colorectal cancer lesions. Genome Biol. 2014;15:454 pubmed publisher

Peng H, Dara L, Li T, Zheng Y, Yang H, Tomasi M, et al. MAT2B-GIT1 interplay activates MEK1/ERK 1 and 2 to induce growth in human liver and colon cancer. Hepatology. 2013;57:2299-313 pubmed publisher

Yao Z, Flash I, Raviv Z, Yung Y, Asscher Y, Pleban S, et al. Non-regulated and stimulated mechanisms cooperate in the nuclear accumulation of MEK1. Oncogene. 2001;20:7588-96 pubmed